Perosphere Technologies Inc.

01/11/2022

We are seeking healthy people who are interested in participating in our blood donation study.

Criteria:
1. Do not take medications that are designed to alter the coagulation process

2. 18 to 75 years old

Qualified participants may receive up to $100.00 in compensation for their time

If you are interested in participating in our study, please call (475) 218-4670

Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics and medical device-based drug delivery systems.

12/08/2021

We are seeking Xarelto (rivaroxaban), Eliquis (apixaban), Pradaxa (dabigatran), or Coumadin (warfarin) patients, who are interested in participating in a 1/2-day blood donation study.

3 blood draws are required (up to 45mL, approx. 3 tablespoons total)

Criteria:
1. Xarelto (rivaroxaban), Eliquis (apixaban), Pradaxa (dabigatran), or Coumadin (warfarin)for an underlying condition
2. 18 to 75 years old
3. Have taken their prescribed anticoagulant regularly at least for a month prior to study participation

Qualified participants may receive up to $200.00 in compensation for their time.

If you are interested in participating in our study, please call (475) 218-4670

Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics and medical device-based drug delivery systems.

12/08/2021

We are looking for healthy volunteers to participate in our blood study.

Eligible volunteers can earn up to $100.00 for their participation.

Call (475) 218-4670 to apply!

Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics and medical device-based drug delivery systems.

10/19/2021

We are seeking Xarelto (rivaroxaban) or Eliquis (apixaban) patients, who are interested in participating in a 1/2 day blood donation study.
3 blood draws are required (up to 45mL, approx 3 tablespoons total).
Criteria:
1. Have physician-prescribed Eliquis (apixaban) or Xarelto (rivaroxaban) for an underlying
condition
2. 18 to 75 years old
3. Have taken their prescribed anticoagulant regularly at least for a month prior to study participation
Qualified participants may receive up to $200.00 in compensation for their time.
If you are interested in participating in our study please call (475) 218-4670

07/30/2021

We are seeking Xarelto (rivaroxaban) or Eliquis (apixaban) patients, who are interested in participating in a 1/2 day blood donation study.
3 blood draws are required (up to 45mL, approx 3 tablespoons total).
Criteria:
1. Have physician-prescribed Eliquis (apixaban) or Xarelto (rivaroxaban) for an underlying
condition
2. 18 to 75 years old
3. Have taken their prescribed anticoagulant regularly at least for a month prior to study participation
Qualified participants may receive up to $200.00 in compensation for their time.
If you are interested in participating in our study please call (475) 218-4670

Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics and medical device-based drug delivery systems.

05/10/2021

A major milestone for Perosphere Technologies! Today, we announced the CE-IVD Marking of our PoC Coagulometer System which allows us to begin commercialization throughout the EU! We are excited to offer healthcare providers in the EU and other international markets a first-in-class solution for DOAC and low molecular heparin coagulation testing at the point of care, and believe our PoC Coagulometer System will change the paradigm for managing DOAC and heparin therapy in emergency settings and beyond. Read the full press release below.

/PRNewswire/ -- Perosphere Technologies Inc. today announced CE (Conformité Européene)-IVD Marking of its Point-of-Care (PoC) Coagulometer System. The CE Mark...

10/13/2020

On and every day it's critical to know the signs and symptoms of a blood clot. It could save your life. Learn more at World Thrombosis Day.

10/12/2020

Listen in to tomorrow's to get the very latest information about COVID-19 and clots.

10/09/2020

October is Breast Cancer Awareness Month. Know the facts about blot clot risks and breast cancer at http://bit.ly/2ouPua5

10/01/2020

The country is running out of blood. Months of social distancing and stay-at-home orders have resulted in fewer blood donations and a staggering drop in supplies. You can help. Schedule your donation today. https://www.redcrossblood.org/give.html/find-drive
Danbury Fair blood drive TODAY and throughout the Fall!

09/29/2020

We lend our voice to ❤️ to help inform people around the globe about cardiovascular disease, the world's number one killer. Together, we can to beat .

09/25/2020

Platelets are cells in our blood required to maintain the integrity of our blood vessel walls and for blood to clot. Without a sufficient number of platelets, a person with ITP (immune thrombocytopenia) is subject to spontaneous bleeding or bruising. Perosphere Technologies supports the good work being done at the Platelet Disorder Support Association to support and empower the ITP community.